4 ms·
We somehow came out of that same Vox article with very different impressions. 90% effective against the North American strain of Lyme for everyone 15 and older
by Wowfunhappy 7y ago
We somehow came out of that same Vox article with very different impressions. 90% effective against the North American strain of Lyme for everyone 15 and older sounds pretty darn great to me. I certainly want it.
It's great that there is a new vaccine under development, but it's likely years away, if it even completes its later phase trials at all. How about we use what we have?
- ghaff 7y agoThat's a pretty glass half-full summary of the data. I'd recommend reading this retrospective (linked from the article) for more detail: https://academic.oup.com/cid/article/52/suppl_3/s253/444754 https://academic.oup.com/cid/article/52/suppl_3/s253/444754 It's also a vaccine that, among other things, probably required multiple shots and maybe annual boosters. To be sure, Lyme has become a bigger problem since that vaccine was pulled and, with the benefit of hindsight, it probably should be available for high-risk adult populations in spite of the risks. Of course, it would probably have to be added to the National Vaccine Injury Compensation Program so the manufacturer couldn't be sued. Probably academic anyway as there is hopefully a better vaccine from a French company in the pipeline.
- magduf 7y ago>It's also a vaccine that, among other things, probably required multiple shots and maybe annual boosters. Hepatitis C vaccine also requires multiple shots (3), though no annual boosters. What's the problem?
- foobiekr 7y agoWould you want it if you discovered after the fact that you had the genotype to acquire Lymerix-triggered arthritis as a result? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2870557/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2870557/
- smush 7y agoThe GPs comment has a link to a Vox article that indicates that "Lymerix-triggered arthritis" was never more than a hypothetical posed by some of the members of the FDA review board. No hard evidence of that condition exists. In a sample of 150,000 recipients, only 59 people later reported arthritic symptoms later - no higher than unvaccinated rates. The vaccine was withdrawn before additional studies could provide full empirical evidence that there was no relationship, granted. But the preliminary samples for a lack of full study seem to show the vaccine was just fine, but for some reason the market got spooked.